These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36077368)

  • 21. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired Fasting-Induced Adaptive Lipid Droplet Biogenesis in Liver-Specific Atg5-Deficient Mouse Liver Is Mediated by Persistent Nuclear Factor-Like 2 Activation.
    Li Y; Chao X; Yang L; Lu Q; Li T; Ding WX; Ni HM
    Am J Pathol; 2018 Aug; 188(8):1833-1846. PubMed ID: 29803835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
    Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
    EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling.
    Liu X; Zhang Y; Ma C; Lin J; Du J
    Mol Biol Rep; 2022 Apr; 49(4):3113-3122. PubMed ID: 35107741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicolor Two-Photon Microscopy Imaging of Lipid Droplets and Liver Capsule Macrophages In Vivo.
    Kim ES; Lee JM; Kwak JY; Lee HW; Lee IJ; Kim HM
    Anal Chem; 2024 May; 96(21):8467-8473. PubMed ID: 38723271
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Purevsuren K; Shiozaki S; Mizukami K; Tobita S; Yoshihara T
    Anal Chem; 2023 Feb; 95(7):3729-3735. PubMed ID: 36759196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease.
    Chikamatsu M; Watanabe H; Shintani Y; Murata R; Miyahisa M; Nishinoiri A; Imafuku T; Takano M; Arimura N; Yamada K; Kamimura M; Mukai B; Satoh T; Maeda H; Maruyama T
    J Control Release; 2023 Mar; 355():42-53. PubMed ID: 36690035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ban-xia-xie-xin-tang ameliorates hepatic steatosis by regulating Cidea and Cidec expression in HFD-fed mice.
    Xia QS; Gao Y; Wen-Bin W; Wu F; Dong H; Xu LJ; Fang K; Hu ML; Yuan F; Lu FE; Gong J
    Phytomedicine; 2022 Oct; 105():154351. PubMed ID: 35908522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway.
    Xu N; Luo H; Li M; Wu J; Wu X; Chen L; Gan Y; Guan F; Li M; Su Z; Chen J; Liu Y
    Biomed Pharmacother; 2021 Feb; 134():111104. PubMed ID: 33341045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD.
    Li H; Dun Y; Zhang W; You B; Liu Y; Fu S; Qiu L; Cheng J; Ripley-Gonzalez JW; Liu S
    Life Sci; 2021 May; 273():119314. PubMed ID: 33667513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.
    Lohr K; Pachl F; Moghaddas Gholami A; Geillinger KE; Daniel H; Kuster B; Klingenspor M
    Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pterostilbene and Its Derivative 3'-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway.
    Tsai HY; Shih YY; Yeh YT; Huang CH; Liao CA; Hu CY; Nagabhushanam K; Ho CT; Chen YK
    J Agric Food Chem; 2022 Apr; 70(16):4966-4980. PubMed ID: 35416649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
    Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
    Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Different Mechanisms of Lipid Accumulation in Hepatocytes Induced by Oleic Acid/Palmitic Acid and High-Fat Diet.
    Zhang M; Bai X; Du Q; Xu J; Wang D; Chen L; Dong K; Chen Z; Yang J
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.